Medical radioisotopes market is expanding exponentially and immensely influenced by the increasing demand for diagnostic imaging and therapeutic usage of medical practice The increasing incidence of chronic diseases such as cancer and cardiovascular disease is increasing demand for sophisticated imaging modalities such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT).
These imaging techniques are highly reliant on medical radioisotopes, particularly fluorine-18 and technetium-99m, in order to make accurate diagnosis and treatment planning.
Secondly, pharmaceutical development of radiopharmaceuticals is enhancing the efficiency of targeted therapy, primarily in oncology. The accuracy of administering accurate radiation doses to cancer cells minimizes harm to neighboring healthy tissues and hence leads to improved patient outcomes as well as lower side effects.
This shift in focus toward personalized medicine is also propelling innovation within the industry as healthcare providers are seeking new ways of personalizing treatments to meet the unique needs of individual patients.
In addition, increased research and development expenditure, along with collaborative research among pharmaceutical companies and research institutions is expected to drive innovation in the production and use of medical radioisotopes. Overall, the medical radioisotopes market is likely to experience robust growth driven by technology developments, increasing disease incidence, and trend towards more targeted health care solutions.
Medical radioisotopes imply radioactive substances used for diagnosing and treating various medical conditions, particularly in oncology, cardiology, and neurology. Such isotopes emit radiation that can be detected by imaging devices, thereby allowing healthcare professionals to visualize and assess internal bodily functions and structures.
Commonly used medical radioisotopes are inclusive of technetium-99m, which is broadly employed in diagnostic imaging owing to its ideal properties and iodine-131 utilized for treating thyroid disorders.
The applications of medical radioisotopes extend beyond diagnostics. They also play a crucial role in targeted therapies, delivering precise radiation doses to cancerous tissues while minimizing damage to surrounding healthy cells. The growing prevalence of chronic diseases and advancements in radiopharmaceuticals is driving demand for these isotopes.
As research continues to evolve, the development of new radioisotopes and innovative applications is expected to enhance patient care and improve treatment outcomes, solidifying their importance in modern medicine.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Growing demand for nuclear medicine is one of the key growth drivers to the medical radioisotopes market. Nuclear medicine, including the application of radioactive material in diagnosis and treatment, is being widely used by patients and doctors.
This growing awareness is a result of the numerous education campaigns, advanced imaging modalities, and rising prevalence of chronic diseases such as cancer and cardiovascular disease. The higher the education of medical physicians in the applications and benefits of nuclear medicine, the more probable is the likelihood of it being utilized as part of the treatment by the patient.
Patients have also been more educated, and number of individuals are seeking newer diagnostic modalities and treatments. As awareness of the usefulness of modalities like PET and SPECT scans grows among the public, the demand for medical radioisotopes will continue to grow. These imaging tests are non-surgical and provide useful information regarding disease progression, which will aid in treatment planning.
Besides, personalized medicine is working toward making nuclear medicine more preferable as it allows individualized treatment with least side-effects but maximum therapeutic effect. Collaboration between research institutes and pharmaceutical firms is driving innovation, which is resulting in novel radioisotopes and applications.
The increased demand for personalized medicine is one of the major market drivers to the medical radioisotopes market as healthcare is trending toward patient-specific treatment plans individually tailored as per the needs of an individual.
Personalized medicine according to genetic, environmental, and lifestyle determinants in line with personalized medicine is compatible with the applications of medical radioisotopes. These isotopes focus on targeted therapy where the appropriate dose of radiation is delivered to diseased tissue and minimal harm is caused to adjacent normal tissue with maximal therapeutic effect.
With patients and clinicians wanting improved and less toxic therapy, the role of medical radioisotopes is even more important. Radioisotopes, for instance, can be used in targeted cancer radiotherapy to create therapies tailored to a patient's tumor molecular signature. This is not only maximized for result but reduces side-effects, which aids with and meets compliance with treatment.
The cardiology application market leads the medical radioisotopes market worldwide due to the increasing prevalence of cardiovascular diseases (CVDs) and the pivotal use of nuclear imaging in the diagnosis and treatment of the same.
As CVDs remain a prime cause of morbidity and mortality worldwide, demand for effective diagnostic mechanisms has picked up pace. Clinical radioisotopes such as technetium-99m and thallium-201 find extensive use in a range of cardiac imaging techniques, ranging from myocardial perfusion imaging and stress tests, which are used in heart function and failure diagnosis.
Besides, advancements in imaging technology have further increased the specificity and sensitivity of nuclear medicine modalities in cardiology. The advancements enable physicians to obtain satisfactory information regarding the state of the heart, therefore enabling interventions on time as well as appropriate therapy planning, this informs.
Non-invasive is also the characteristic that makes the imaging technologies quite popular among physicians as well as patients since they reduce the need for more invasive diagnostic methods.
Moreover, greater awareness among physicians for the benefits of nuclear medicine in cardiology is driving its adoption. Rising patient age and lifestyle risk factors responsible for the growing number of CVDs are pushing the cardiology application segment to continue leading the medical radioisotopes market, with growing diagnostic capability and patient results.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest analysis of the medical radioisotopes market, North America held the largest market share in 2024 due to the region being home to well-developed medical infrastructure with highly developed medical facilities and equipment. It is such an infrastructure that sustains massive utilization of nuclear medicine, hence allowing for the use of medical radioisotopes in treatment and diagnosis.
Second, there has been an unprecedented increase in the number of chronic diseases such as cancer and cardiovascular diseases, which give rise to new diagnostic and therapeutic modalities. With clinicians seeking effective ways of treating such diseases, nuclear medicine has emerged as a valuable tool for targeted diagnosis and tailored treatment.
Moreover, incentive through regulation and supportive reimbursement in Canada and the United States enables use of medical radioisotopes among more patient populations. These compounded factors position North America in leadership of the medical radioisotopes market, driving expansion and improving nuclear medicine patient care.
Siemens Healthineers, Lantheus Holdings, Abbott Laboratories, Eli Lilly, Sanofi, Orano, Rosatom, Cardinal Health, Curium, IBA Radiopharma Solutions, NorthStar Medical Radioisotopes, BWX Technologies, Shine Medical Technologies, NECSA Ltd are some of the leading key players operating in the medical radioisotopes industry.
Each of these players have been have been profiled in the medical radioisotopes market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 5.9 Bn |
| Forecast Value in 2035 | US$ 14.1 Bn |
| CAGR | 8.1% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2024 |
| Quantitative Units | US$ Bn |
| Medical Radioisotopes Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 5.9 Bn in 2024.
It was projected to cross US$ 14.1 Bn by the end of 2035.
Growing awareness of nuclear medicine and rising demand for personalized medicine.
It is projected to advance at a CAGR of 8.1% from 2025 to 2035.
North America was the dominant region in 2024.
Siemens Healthineers, Lantheus Holdings, Abbott Laboratories, Eli Lilly, Sanofi, Orano, Rosatom, Cardinal Health, Curium, IBA Radiopharma Solutions, NorthStar Medical Radioisotopes, BWX Technologies, Shine Medical Technologies, NECSA Ltd, and others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Medical Radioisotopes Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Radioisotopes Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Recent Advancements
5.2. PORTER’s Five Forces Analysis
5.3. PESTEL Analysis
5.4. Value Chain Analysis
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.7. Regulatory Scenario by Key Country
5.8. Research and Development Trends
5.9. Go-to-Market Strategy for New Market Entrants
6. Global Medical Radioisotopes Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2035
6.3.1. Technetium-99m
6.3.2. Gallium-67
6.3.3. Iodine-131
6.3.4. Copper-67
6.3.5. Cobalt-60
6.3.6. Strontium-82
6.3.7. Germanium-68
6.3.8. Rubidium-82
6.3.9. Thallium-201
6.3.10. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Medical Radioisotopes Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2035
7.3.1. Cardiology
7.3.2. Oncology
7.3.3. Neurology
7.3.4. Nephrology
7.3.5. Thyroid
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Medical Radioisotopes Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2035
8.3.1. Hospitals
8.3.2. Diagnostics Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Medical Radioisotopes Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2035
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Medical Radioisotopes Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2020-2035
10.2.1. Technetium-99m
10.2.2. Gallium-67
10.2.3. Iodine-131
10.2.4. Copper-67
10.2.5. Cobalt-60
10.2.6. Strontium-82
10.2.7. Germanium-68
10.2.8. Rubidium-82
10.2.9. Thallium-201
10.2.10. Others
10.3. Market Value Forecast, by Application, 2020-2035
10.3.1. Cardiology
10.3.2. Oncology
10.3.3. Neurology
10.3.4. Nephrology
10.3.5. Thyroid
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2020-2035
10.4.1. Hospitals
10.4.2. Diagnostics Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Medical Radioisotopes Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2020-2035
11.2.1. Technetium-99m
11.2.2. Gallium-67
11.2.3. Iodine-131
11.2.4. Copper-67
11.2.5. Cobalt-60
11.2.6. Strontium-82
11.2.7. Germanium-68
11.2.8. Rubidium-82
11.2.9. Thallium-201
11.2.10. Others
11.3. Market Value Forecast, by Application, 2020-2035
11.3.1. Cardiology
11.3.2. Oncology
11.3.3. Neurology
11.3.4. Nephrology
11.3.5. Thyroid
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2020-2035
11.4.1. Hospitals
11.4.2. Diagnostics Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2035
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Medical Radioisotopes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2035
12.2.1. Technetium-99m
12.2.2. Gallium-67
12.2.3. Iodine-131
12.2.4. Copper-67
12.2.5. Cobalt-60
12.2.6. Strontium-82
12.2.7. Germanium-68
12.2.8. Rubidium-82
12.2.9. Thallium-201
12.2.10. Others
12.3. Market Value Forecast, by Application, 2020-2035
12.3.1. Cardiology
12.3.2. Oncology
12.3.3. Neurology
12.3.4. Nephrology
12.3.5. Thyroid
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2020-2035
12.4.1. Hospitals
12.4.2. Diagnostics Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Medical Radioisotopes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2035
13.2.1. Technetium-99m
13.2.2. Gallium-67
13.2.3. Iodine-131
13.2.4. Copper-67
13.2.5. Cobalt-60
13.2.6. Strontium-82
13.2.7. Germanium-68
13.2.8. Rubidium-82
13.2.9. Thallium-201
13.2.10. Others
13.3. Market Value Forecast, by Application, 2020-2035
13.3.1. Cardiology
13.3.2. Oncology
13.3.3. Neurology
13.3.4. Nephrology
13.3.5. Thyroid
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2020-2035
13.4.1. Hospitals
13.4.2. Diagnostics Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Medical Radioisotopes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2035
14.2.1. Technetium-99m
14.2.2. Gallium-67
14.2.3. Iodine-131
14.2.4. Copper-67
14.2.5. Cobalt-60
14.2.6. Strontium-82
14.2.7. Germanium-68
14.2.8. Rubidium-82
14.2.9. Thallium-201
14.2.10. Others
14.3. Market Value Forecast, by Application, 2020-2035
14.3.1. Cardiology
14.3.2. Oncology
14.3.3. Neurology
14.3.4. Nephrology
14.3.5. Thyroid
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2020-2035
14.4.1. Hospitals
14.4.2. Diagnostics Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2024)
15.3. Company Profiles
15.3.1. Siemens Healthineers
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Lantheus Holdings
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Abbott Laboratories
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Eli Lilly
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Sanofi
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Orano
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Rosatom
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Cardinal Health
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Curium
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. IBA Radiopharma Solutions
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. NorthStar Medical Radioisotopes
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments
15.3.12. BWX Technologies
15.3.12.1. Company Overview
15.3.12.2. Financial Overview
15.3.12.3. Product Portfolio
15.3.12.4. Business Strategies
15.3.12.5. Recent Developments
15.3.13. Shine Medical Technologies
15.3.13.1. Company Overview
15.3.13.2. Financial Overview
15.3.13.3. Product Portfolio
15.3.13.4. Business Strategies
15.3.13.5. Recent Developments
15.3.14. NECSA Ltd
15.3.14.1. Company Overview
15.3.14.2. Financial Overview
15.3.14.3. Product Portfolio
15.3.14.4. Business Strategies
15.3.14.5. Recent Developments
List of Tables
Table 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 02: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 03: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 04: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 05: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 06: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 07: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 08: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 09: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 10: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 11: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 12: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 13: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 15: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 16: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 17: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 18: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 19: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 20: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 21: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 22: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Type, 2020-2035
Table 23: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 24: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, By End-user, 2020-2035
List of Figures
Figure 01: Global Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 02: Global Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 03: Global Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 04: Global Medical Radioisotopes Market Revenue (US$ Bn), by Technetium-99m, 2020-2035
Figure 05: Global Medical Radioisotopes Market Revenue (US$ Bn), by Gallium-67, 2020-2035
Figure 06: Global Medical Radioisotopes Market Revenue (US$ Bn), by Iodine-131, 2020-2035
Figure 07: Global Medical Radioisotopes Market Revenue (US$ Bn), by Copper-67, 2020-2035
Figure 08: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cobalt-60, 2020-2035
Figure 09: Global Medical Radioisotopes Market Revenue (US$ Bn), by Strontium-82, 2020-2035
Figure 10: Global Medical Radioisotopes Market Revenue (US$ Bn), by Germanium-68, 2020-2035
Figure 11: Global Medical Radioisotopes Market Revenue (US$ Bn), by Rubidium-82, 2020-2035
Figure 12: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thallium-201, 2020-2035
Figure 13: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
Figure 14: Global Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 15: Global Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 16: Global Medical Radioisotopes Market Revenue (US$ Bn), by Cardiology, 2020-2035
Figure 17: Global Medical Radioisotopes Market Revenue (US$ Bn), by Oncology, 2020-2035
Figure 18: Global Medical Radioisotopes Market Revenue (US$ Bn), by Neurology, 2020-2035
Figure 19: Global Medical Radioisotopes Market Revenue (US$ Bn), by Nephrology, 2020-2035
Figure 20: Global Medical Radioisotopes Market Revenue (US$ Bn), by Thyroid, 2020-2035
Figure 21: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
Figure 22: Global Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 23: Global Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Figure 24: Global Medical Radioisotopes Market Revenue (US$ Bn), by Hospitals, 2020-2035
Figure 25: Global Medical Radioisotopes Market Revenue (US$ Bn), by Diagnostic Centers, 2020-2035
Figure 26: Global Medical Radioisotopes Market Revenue (US$ Bn), by Others, 2020-2035
Figure 27: Global Medical Radioisotopes Market Value Share Analysis, By Region, 2024 and 2035
Figure 28: Global Medical Radioisotopes Market Attractiveness Analysis, By Region, 2025-2035
Figure 29: North America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 30: North America - Medical Radioisotopes Market Value Share Analysis, by Country, 2024 and 2035
Figure 31: North America - Medical Radioisotopes Market Attractiveness Analysis, by Country, 2025-2035
Figure 32: North America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 33: North America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 34: North America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 35: North America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 36: North America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 37: North America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Figure 38: Europe - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 39: Europe - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 40: Europe - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 41: Europe - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 42: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 43: Europe - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 44: Europe - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 45: Europe - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 46: Europe - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Figure 47: Asia Pacific - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 48: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 49: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
Figure 50: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 51: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 52: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 53: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 54: Asia Pacific - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 55: Asia Pacific - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Figure 56: Latin America - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 57: Latin America - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 58: Latin America - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 59: Latin America - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 60: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 61: Latin America - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 62: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 63: Latin America - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 64: Latin America - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Figure 65: Middle East & Africa - Medical Radioisotopes Market Value (US$ Bn) Forecast, 2020-2035
Figure 66: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 67: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
Figure 68: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Type, 2024 and 2035
Figure 69: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Type, 2025-2035
Figure 70: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By Application, 2024 and 2035
Figure 71: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By Application, 2025-2035
Figure 72: Middle East & Africa - Medical Radioisotopes Market Value Share Analysis, By End-user, 2024 and 2035
Figure 73: Middle East & Africa - Medical Radioisotopes Market Attractiveness Analysis, By End-user, 2025-2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Medical Radioisotopes Market
